CClinicalTrials.gg
RecruitingNCT06804226ADVISEUpdated Mar 30, 2025

Advancing Discussions Using a Video-based Support Tool About End-of-life Care

An interventional study of Video conversation aid and Usual Care in Traumatic Injury, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-03-30.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
270
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness and implementation considerations of a video aid to improve communication and patient-centered outcomes in older injured adults

02

Conditions studied

  • Traumatic Injury
03

In context

Death

572 studies on the registry are indexed under Death; 111 are open to participants now.

This study's planned enrollment of 270 is above the median of 133 across 260 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • English or Spanish speaking
  • admitted to any level of care following trauma

Exclusion criteria

Exclusion Criteria:

  • Prisoners
  • Existing do not resuscitate (DNR)/do not intubate (DNI)
  • Patients admitted while on hospice
  • Patients not expected to survive over 24-48 hours
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
270 participants (estimated)

Study arms

  • Experimental
    Video conversation aid

    Behavioral: Video conversation aid

  • Active comparator
    Usual Care

    Behavioral: Usual Care

Interventions

  • BehavioralVideo conversation aid

    A video conversation aid which provides information regarding life-sustaining care and encourages further goals of care discussions with a healthcare provider will be shown to patients or their surrogates (for those incapacitated and unable to make their own decisions) on admission or within 48 hours whenever feasible

  • BehavioralUsual Care

    Participants and/or surrogates will participate in discussions surrounding life-sustaining care at healthcare provider discretion.

06

What researchers measure

Primary outcomes

  1. Number of participants who had a transition in code status from full code

    Data will be reported categorically as number of participants who transitioned from full code to DNR/DNI, DNR, ok for intubation, or Comfort measures only

    Time frame: at time of discharge (about 5 days after admission)

Secondary outcomes

  1. Percentage of participants that recognize survival after Cardiopulmonary resuscitation (CPR) as less than 50 percent as assessed by a survey

    Time frame: at time of discharge (about 5 days after admission)

  2. Number of participants that received information about life-sustaining care outcomes as assessed by a survey

    Time frame: at time of discharge (about 5 days after admission)

  3. Number of participants that desire more information regarding life-sustaining care as assessed by a survey

    Time frame: at time of discharge (about 5 days after admission)

  4. Number of participants that had hospital-free days

    Time frame: in the first 30 days after admission

  5. Number of participants that had ICU-free days

    Time frame: at time of discharge (about 5 days after admission)

  6. Discharge disposition

    Data will be reported categorically as number of participants that were discharged to home, nursing facility, rehab facility, long term care hospital, hospice or number of participants that die

    Time frame: at time of discharge (about 5 days after admission)

  7. Number of participants that had ventilator-free days

    Time frame: at time of discharge (about 5 days after admission)

  8. Decisional conflict score as assessed by the Decisional Conflict Scale

    This is a 4 item questionnaire, each is scored as 0(no) or 1(yes), for a maximum score of 4, higher score indicating no decisional conflict

    Time frame: at time of discharge (about 5 days after admission)

  9. Number of interventional procedures

    Procedures include tracheostomy, feeding tube placement, dialysis initiation

    Time frame: at time of discharge (about 5 days after admission)

07

Study locations

1 of 1 sites recruiting
  • The University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06804226
Lead sponsor
The University of Texas Health Science Center, Houston
Responsible party
Thaddeus J. Puzio (Assistant Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Feb 3, 2025
Start date
Mar 17, 2025
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 1, 2026 (estimated)
Last update
Mar 30, 2025

Study contacts

Thaddeus J Puzio, MD, MS, FACS
Contact
Thaddeus.J.Puzio@uth.tmc.edu
713-500-7218
Erin Fox
Contact
Erin.E.Fox@uth.tmc.edu
(713) 500-7965
Thaddeus J Puzio, MD, MS, FACS
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion